Dextroamphetamine sulfate

Drug ingredientActive Shortage

CAS 51-63-8

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

US productionNot reported

Import value, 2024$4M

Top sourceGermany 95%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 292146 · basket

These shares come from HS customs code 292146, which covers 9 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

DE 95%GermanyIT 5%Italy

India
United Kingdom

42 FDA-registered drug labelers

Actavis Pharma, Inc.

Adare Pharmaceuticals Inc

Alvogen Inc.

Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals of New York LLC

ANI Pharmaceuticals, Inc.

Aurolife Pharma, LLC

Azurity Pharmaceuticals, Inc.

Bryant Ranch Prepack

Burel Pharmaceuticals, LLC

Camber Pharmaceuticals, Inc.

Cambrex Charles City, Inc

Catalent Pharma Solutions, LLC

Chattem Chemicals, Inc.

Cranbury Pharmaceuticals, LLC

Curia New York, Inc.

Elite Laboratories, Inc.

Epic Pharma, LLC

GLENMARK PHARMACEUTICALS INC., USA

Golden State Medical Supply, Inc.

Granules Pharmaceuticals Inc.

INDEPENDENCE PHARMACEUTICALS, LLC

KVK-Tech, Inc.

Lannett Company, Inc.

Lupin Pharmaceuticals,Inc.

Neolpharma, Inc.

NorthStar RxLLC

Oryza Pharmaceuticals Inc.

Patheon Manufacturing Services LLC

Prasco Laboratories

Rhodes Pharmaceuticals L.P.

Sandoz Inc

Siegfried USA, LLC

SpecGx LLC

Sun Pharmaceutical Industries, Inc.

SUNRISE PHARMACEUTICAL, INC.

Takeda Pharmaceuticals America, Inc.

Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals, Inc.

Veranova, L.P.

Wilshire Pharmaceuticals, Inc.

Winder Laboratories LLC

Why It Matters

Sectors

Health

Downstream Uses

Appears in 19 drug and cosmetic product listings (FDA).

•Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
•Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
•Dextroamphetamine Sulfate
•Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII
•Mydayis
•Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate
•Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
•Mixed Salts of a Single-Entity Amphetamine Product

Show all 19

•Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
•Mixed Salts of a Single Entity Amphetamine Product XR
•Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release
•Adderall
•Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release
•Zenzedi
•Dextroamphetamine
•Adderall XR
•Procentra
•Dextroamphetamine Sulfate Extended-Release
•Dexedrine Spansule

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

Active Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

Current shortage
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Shortage listed since October 12, 2022
Manufacturer reports: 1 unavailable, 3 limited, 2 available

See all current drug shortages

Chemical Identity

CAS51-63-8

PubChem CID5825

DTXSIDDTXSID2057865

FormulaC18H28N2O4S

Mol. Weight368.5 g/mol

SMILESCC(CC1=CC=CC=C1)N.CC(CC1=CC=CC=C1)N.OS(=O)(=O)O

Data Sources

PubChem · compound 5825Retrieved 2026-04-07
FDA National Drug Code directoryRetrieved 2026-04-25
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Dextroamphetamine sulfate (CAS 51-63-8) https://chemicalindependence.com/chemical/51-63-8/ PubChem: 5825. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/5825 FDA National Drug Code directory: CAS 51-63-8. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 51-63-8. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 292146 for CAS 51-63-8. Reporting year: 2024. https://usatrade.census.gov/